يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"INFECTION"', وقت الاستعلام: 1.20s تنقيح النتائج
  1. 1
    تقرير
  2. 2
    تقرير
  3. 3
    تقرير
  4. 4
    تقرير

    المصدر: A Randomized Phase II Trial of Concurrent Chemotherapy and Pelvic Radiation Therapy With or Without Paclitaxel and Carboplatin in HIV-positive Women With Locally Advanced Cervical Cancer (LACC)

  5. 5
    تقرير

    المصدر: A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection

  6. 6
    تقرير

    المصدر: A Phase I Study of Ipilimumab and Nivolumab in Advanced HIV Associated Solid Tumors With an Expansion Cohort in HIV Associated Solid Tumors and a Cohort of HIV-Associated Classical Hodgkin Lymphoma

  7. 7
    تقرير

    المصدر: Fuchshuber PR, Rodruez-Bas M, Weber T, PetrellNJ. Anal canal and pernal epermo cancers. J Am Coll Surg. 1997 Nov;185(5):494-505. do 10.1016/s1072-7515(97)00094-x. Erratum : J Am Coll Surg 1998 Jan;186(1):112.
    Steele SR, Varma MG, Melton GB, Ross HM, Rafferty JF, Bu WD; Standards Practe Task Force of the Ameran Socty of Colon and Rectal Surgeons. Practe parameters for anal squamous neoplasms. D Colon Rectum. 2012 Jul;55(7):735-49. do 10.1097/DCR.0b013e318255815e. No abstract avaable.
    Benson AB, Venook AP, Al-Hawary MM, Cederqut L, Chen YJ, Cmbor KK, Cohen S, Cooper HS, Demg D, Engstrom PF, Garro-Laguna Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kcuk N, KrhnamurthS, Messersmh WA, Meyerhardt J, Mler ED, Mulcahy MF, Murphy JD, Nurk S, Saltz L, Sharma S, Shata D, Skber JM, Sofocleous CT, Stoffel EM, Stotsky-Helfarb E, Wlett CG, Wuthrk E, Gregory KM, Freedman-Cass DA. NCCN Gueles shts: Colon Cancer, Versn 2.2018. J Natl Compr Canc Netw. 2018 Apr;16(4):359-369. do 10.6004/jnccn.2018.0021.
    Leonard D, Beddy D, Dozo EJ. Neoplasms of anal canal and pernal sk. Cl Colon Rectal Surg. 2011 Mar;24(1):54-63. do 10.1055/s-0031-1272824.
    Oehler-Janne C, Huguet F, Provencher S, Seert B, NegrettL, Rner MO, Bonet M, Allal AS, Crn . H-spec dferences outcome of squamous cell carcoma of the anal canal: a multentr cohort study of H-pose patnts receg hhly acte antetroval therapy. J Cl Oncol. 2008 May 20;26(15):2550-7. do 10.1200/JCO.2007.15.2348. Epub 2008 Apr 21.
    Wexler A, Berson AM, Goldstone SE, Waltzman R, Penzer J, Maonet OG, McDermott B, Rescno J. vase anal squamous-cell carcoma the H-pose patnt: outcome the era of hhly acte antetroval therapy. D Colon Rectum. 2008 Jan;51(1):73-81. do 10.1007/s10350-007-9154-7. Epub 2007 Dec 8.
    Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, McCalmont T, Nayar R, Palefsky JM, Stoler MH, Wkson EJ, Zao RJ, Wbur DC; Members of LAST Project Work Groups. The Lower Anogenal Squamous Termology Standardatn Project for HPV-Assocted Lesns: background and consensus recommendatns from the College of Ameran Pathologts and the Ameran Socty for Colposcopy and Cerval Pathology. J Low Gen Tract D. 2012 Jul;16(3):205-42. do 10.1097/LGT.0b013e31825c31dd. Erratum : J Low Gen Tract D. 2013 Jul;17(3):368.
    Beahrs OH, Wson SM. Carcoma of the anus. Ann Surg. 1976 Oct;184(4):422-8. do 10.1097/00000658-197610000-00004.
    Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malnant tumors of the anal canal: the spectrum of dease, treatment, and outcomes. Cancer. 1999 Apr 15;85(8):1686-93. do 10.1002/(s1097-0142(19990415)85:83.0.co;2-7.
    Chang GJ, Berry JM, Jay N, Palefsky JM, Welton ML. Surgal treatment of hh-grade anal squamous traephell lesns: a prospecte study. D Colon Rectum. 2002 Apr;45(4):453-8. do 10.1007/s10350-004-6219-8.
    Peda CE, Berry JM, Jay N, Palefsky JM, Welton ML. Hh-resolutn anoscopy targeted surgal destructn of anal hh-grade squamous traephell lesns: a ten-year expernce. D Colon Rectum. 2008 Jun;51(6):829-35; dcussn 835-7. do 10.1007/s10350-008-9233-4. Epub 2008 Mar 25.
    ZlT, Schk U, Ozsah M, Gervaz P, Roth AD, Allal AS. Node-negate T1-T2 anal cancer: radtherapy alone or concomant chemoradtherapy? Radther Oncol. 2012 Jan;102(1):62-7. do 10.1016/j.radonc.2011.09.015. Epub 2011 Oct 10.
    Ortholan C, RamalA, Pefert D, LuschA, Romestag P, Chauvec L, Touboul E, Penaux K, Bruna A, de La Roche G, Lagrange JL, Alzu C, Gerard JP. Anal canal carcoma: early-stage tumors < or =10 mm (T1 or T): therapeut optns and oral pattern of local faure after radtherapy. t J Radt Oncol Bl Phys. 2005 Jun 1;62(2):479-85. do 10.1016/j.robp.2004.09.060.
    Ortholan C, Resbeut M, Hannoun-LevJM, Tesr E, Gerard JP, Ronch P, Zaccartto A, Msat M, Benezery K, Franco E, Salem N, Ell S, Azr D, Champetr C, Gross E, Cowen D. Anal canal cancer: management of gual nodes and benef of prophylact gual radtn (CORS-03 Study). t J Radt Oncol Bl Phys. 2012 Apr 1;82(5):1988-95. do 10.1016/j.robp.2011.02.010. Epub 2011 May 11.
    Goldstone SE, Hundert JS, Huyett JW. frared coagulator ablatn of hh-grade anal squamous traephell lesns H-negate males who have sex wh males. D Colon Rectum. 2007 May;50(5):565-75. do 10.1007/s10350-006-0874-x.
    Goldstone RN, Goldstone AB, Russ J, Goldstone SE. Long-term follow-up of frared coagulator ablatn of anal hh-grade dysplas men who have sex wh men. D Colon Rectum. 2011 Oct;54(10):1284-92. do 10.1097/DCR.0b013e318227833e.
    Str EA, Goldstone SE, Berry JM, Panther LA, Jay N, Krown SE, Lee J, Palefsky JM. frared coagulator treatment of hh-grade anal dysplas H-fected duals: an AS malnancy consortm pot study. J Acqu mune Def Syndr. 2008 Jan 1;47(1):56-61. do 10.1097/QA0b013e3181582d93.
    Marks DK, Goldstone SE. Electrocautery ablatn of hh-grade anal squamous traephell lesns H-negate and H-pose men who have sex wh men. J Acqu mune Def Syndr. 2012 Mar 1;59(3):259-65. do 10.1097/QA0b013e3182437469.
    Goldstone SE, Johnstone AA, Moshr EL. Long-term outcome of ablatn of anal hh-grade squamous traephell lesns: recurrence and cence of cancer. D Colon Rectum. 2014 Mar;57(3):316-23. do 10.1097/DCR.0000000000000058.
    FALKSON G, SCHULZ EJ. Sk changes patnts treated wh 5-fluorourac. Br J Dermatol. 1962 Jun;74:229-36. do 10.1111/j.1365-2133.1962.tb13497.x. No abstract avaable.
    Maan M, Watts DH, Andersen J, Clax P, Mero M, Kendall MA. Vagal 5-fluorourac for hh-grade cerval dysplas human munodefncy vus fectn: a randomed trl. Obstet Gynecol. 1999 Dec;94(6):954-61. do 10.1016/s0029-7844(99)00407-x.
    Brodman M, Dotto P, Frdman F Jr, Heller D, Blees Sperlg R. Human paplomavus-assocted lesns of the vaga and cerv. Treatment wh a laser and topal 5-fluorourac. J Reprod Med. 1992 May;37(5):453-6.
    Rhel O, Wland U, de Vrs HJ, Brockmeyer NH, van Noesel C, Potthoff A, Prs JM, Kreuter A. Topal 5-fluorourac treatment of anal traephell neoplas human munodefncy vus-pose men. Br J Dermatol. 2010 Dec;163(6):1301-7. do 10.1111/j.1365-2133.2010.09982.x. Epub 2010 Nov 4.
    Rhel O, de Vrs HJ, van Noesel CJ, Dkgraaf MG, Prs JM. Comparon of uod, topal fluorourac, and electrocautery for the treatment of anal traephell neoplas H-pose men who have sex wh men: an open-label, randomed controlled trl. Lancet Oncol. 2013 Apr;14(4):346-53. do 10.1016/S1470-2045(13)70067-6. Epub 2013 Mar 15.
    Graham BD, Jetmore AB, Foote JE, Arnold LK. Topal 5-fluorourac the management of extense anal Bowen's dease: a preferred approach. D Colon Rectum. 2005 Mar;48(3):444-50. do 10.1007/s10350-004-0901-8.
    Mathsen O, Buus SK, Cramers M. Topal uod can reverse vulvar traephell neoplas: a randomed, double-blded study. Gynecol Oncol. 2007 Nov;107(2):219-22. do 10.1016/j.ygyno.2007.06.003. Epub 2007 Jul 25.
    van Seters M, van Beurden M, de Craen AJ. the assumed natural htory of vulvar traephell neoplas based on enough evence? A systemat revw of 3322 publhed patnts. Gynecol Oncol. 2005 May;97(2):645-51. do 10.1016/j.ygyno.2005.02.012.
    PolurRM, Hgs SP. Successful treatment of pene Bowen's dease wh 5% uod cream. t J STD AS. 2005 Sep;16(9):649. do 10.1258/0956462054944444. No abstract avaable.
    RamonS, CusM, GanF, Aranc L, AlessE. Pene traephell carcoma treated wh uod 1% an H-pose patnt. J Dermatolog Treat. 2009;20(3):177-8. do 10.1080/09546630802562435. No abstract avaable.
    Kreuter A, Hochdorfer B, Stucker M, Altmeyer P, Weand U, Conant MA, Brockmeyer NH. Treatment of anal traephell neoplas patnts wh acqued H wh uod 5% cream. J Am Acad Dermatol. 2004 Jun;50(6):980-1. do 10.1016/j.jaad.2003.12.025. No abstract avaable.
    Wagstaff AJ, Perry CM. Topal uod: a revw of s use the management of anogenal warts, act keratoses, basal cell carcoma and other sk lesns. Drugs. 2007;67(15):2187-210. do 10.2165/00003495-200767150-00006.
    Mahto M, Nathan M, O'Mahony C. More than a decade on: revw of the use of uod lower anogenal traephell neoplas. t J STD AS. 2010 Jan;21(1):8-16. do 10.1258/sa.2009.009309.
    Kreuter A, Potthoff A, Brockmeyer NH, Gambhler T, Stucker M, Altmeyer P, Swoboda J, Pfter H, Wland U; German Competence Network H/AS. uod leads to a decrease of human paplomavus DNA and to a sustaed clearance of anal traephell neoplas H-fected men. J vest Dermatol. 2008 Aug;128(8):2078-83. do 10.1038/j.2008.24. Epub 2008 Feb 14.
    Fox PA, Nathan M, Franc N, Sgh N, We J, Don G, Barton SE, Bower M. A double-bld, randomed controlled trl of the use of uod cream for the treatment of anal canal hh-grade anal traephell neoplas H-pose MSM on HAART, wh long-term follow-up data cludg the use of open-label uod. AS. 2010 Sep 24;24(15):2331-5. do 10.1097/QAD.0b013e32833d466c.
    de Sanjose S, Qut WG, Alemany L, Geraets DT, Klaustermer JE, Lloveras B, Tous S, Fel A, Bravo LE, Sh HR, Vallejos CS, de Ru PA, La MA, Guera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, TattSA, Kasamatsu E, jazov E, Oda M, Prado R, Seoud M, Grce M, Usubutun A, Ja A, Suarez GA, LombardLE, Banjo A, Menendez C, Domgo EJ, Velasco J, Nessa A, Chhareon SC, Qo YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, MarnL, Pelayo A, Steer Ola E, Meer CJ, Al-Jassar WF, Cruz E, Wrht TC, Puras A, Llave CL, TzardM, Agorastos T, Garc-Barrla V, Clavel C, OrdJ, Andujar M, Castellsague X, Sanchez G NowakowskAM, Bornste J, Munoz N, Bosch FX; Retrospecte ternatnal Survey and HPV Te Trends Study Group. Human paplomavus genotype attrutn vase cerval cancer: a retrospecte cross-sectnal worldwe study. Lancet Oncol. 2010 Nov;11(11):1048-56. do 10.1016/S1470-2045(10)70230-8. Epub 2010 Oct 15.
    Schlecht NF, Burk RD, Palefsky JM, Mkoff H, Xue X, Massad LS, Bacon M, Leve AM, Anastos K, Gange SJ, Watts DH, Costa MMD, Chen Z, Bang JY, FazzarM, Hall C, Strkler HD. Varnts of human paplomavuses 16 and 18 and the natural htory human munodefncy vus-pose women. J Gen Vol. 2005 Oct;86(Pt 10):2709-2720. do 10.1099/v.0.81060-0.
    Da Costa MM, Hogeboom CJ, Holly EA, Palefsky JM. creased rk of hh-grade anal neoplas assocted wh a human paplomavus type 16 E6 sequence varnt. J fect D. 2002 May 1;185(9):1229-37. do 10.1086/340125. Epub 2002 Apr 16.
    XLF, Crchlow CW, Wheeler CM, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Hawes SE, Surawz C, Goldbaum G, Holmes KK, Kt NB. Rk of anal carcoma su relatn to human paplomavus type 16 varnts. Cancer Res. 1998 Sep 1;58(17):3839-44.
    Schmz M, Drsch C, Jansen L, Runnebaum , Durst M. Non-random tegratn of the HPV genome cerval cancer. PLoS One. 2012;7(6):e39632. do 10.1371/journal.pone.0039632. Epub 2012 Jun 27.
    Meyerson M, Gabrl S, Getz G. Advances understandg cancer genomes through second-generatn sequencg. Nat Rev Genet. 2010 Oct;11(10):685-96. do 10.1038/nrg2841.
    Me KL, Shulzhenko N, Yambartsev A, Rochman M, Sanson GF, Lando M, Varma S, Skner J, Volfovsky N, Deng T, Brenna SM, Carvalho CR, Ralta JC, Bust M, Matzger P, Sva , Lyng H, Gerbase-DeLa M, Morgun A. Gene network reconstructn reveals cell cycle and antal genes as major drers of cerval cancer. Nat Commun. 2013;4:1806. do 10.1038/ncomms2693.
    Schwarz JK, Payton JE, RashmR, Xng T, J Y, Huettner P, Rogers BE, Yang Q, Watson M, Rader JS, Grsby PW. Pathway-spec analys of gene expressn data ents the PK/Akt pathway as a novel therapeut target cerval cancer. Cl Cancer Res. 2012 Mar 1;18(5):1464-71. do 10.1158/1078-0432.CCR-11-2485. Epub 2012 Jan 10.
    Wgo SN, Gallardo TD, Akbay EA, Lng MC, Contreras CM, Boren T, Shamura T, Mler DS, Sharpless NE, Bardeesy N, KwtkowskDJ, Schorge JO, Wong KK, Castrlon DH. Somat LKB1 mutatns promote cerval cancer progressn. PLoS One. 2009;4(4):e5137. do 10.1371/journal.pone.0005137. Epub 2009 Apr 2.
    Heselmeyer K, du Mano S, Blegen H, Frerg B, Svensson C, Schrock E, Veldman T, Shah K, Auer G, Rd T. A recurrent pattern of chromosomal aberratns and munophenotyp appearance defes anal squamous cell carcomas. Br J Cancer. 1997;76(10):1271-8. do 10.1038/bjc.1997.547.
    Heselmeyer K, Macvle M, Schrock E, Blegen H, Hellstrom AC, Shah K, Auer G, Rd T. Advanced-stage cerval carcomas are defed by a recurrent pattern of chromosomal aberratns revealg hh genet staby and a constent ga of chromosome arm 3q. Genes Chromosomes Cancer. 1997 Aug;19(4):233-40.
    Heselmeyer K, Schrock E, du Mano S, Blegen H, Shah K, Stebeck R, Auer G, Rd T. Ga of chromosome 3q defes the transn from severe dysplas to vase carcoma of the utere cerv. Proc Natl Acad ScU S A. 1996 Jan 9;93(1):479-84. do 10.1073/pnas.93.1.479.
    Gagne SE, Jensen R, PolvA, Da Costa M, Gzger D, Efd JT, Holly EA, Darragh T, Palefsky JM. Hh-resolutn analys of genom alteratns and human paplomavus tegratn anal traephell neoplas. J Acqu mune Def Syndr. 2005 Oct 1;40(2):182-9. do 10.1097/01.qa0000179460.61987.33.
    Deshmukh AA, Suk R, Shls MS, Sonawane K, Nyray AG, L Y, Gaa MM, Palefsky JM, Sel K. Recent Trends Squamous Cell Carcoma of the Anus cence and Mortaly the Uned States, 2001-2015. J Natl Cancer st. 2020 Aug 1;112(8):829-838. do 10.1093/jncdjz219.
    Shls MS, Pfefer RM, ChaturvedAK, Kreer AR, Engels EA. pact of the H epem on the cence rates of anal cancer the Uned States. J Natl Cancer st. 2012 Oct 17;104(20):1591-8. do 10.1093/jncdjs371. Epub 2012 Oct 5.
    ChaCY, Tran Cao HS, Awad S, Massarweh NN. Management of Stage Squamous Cell Carcoma of the Anal Canal. JAMA Surg. 2018 Mar 1;153(3):209-215. do 10.1001/jamasurg.2017.3151. Erratum : JAMA Surg. 2018 May 23;153(7):692.
    A Multicenter Observational and Feasibility Study of Excision of Superficially Invasive Squamous Cell Carcinoma (SISCCA) of the Anal Canal and Perianus in HIV-Infected Persons

  8. 8
    تقرير

    المصدر: Phase I Study of MK-3475 (Pembrolizumab) in Patients With Human Immunodeficiency Virus (HIV) and Relapsed/Refractory or Disseminated Malignant Neoplasm